Homburg Saar

Aug 9, 2024 | aacrjournals.org | Homburg Saar |Hye-Jung E

Purpose: Extracranial malignant rhabdoid tumors (eMRT) are a challenging entity. Despite the use of multimodal treatment approaches, therapy failure occurs in 55-67%. Molecular markers for identification of patients at increased risk for relapse or refractory (R/R) disease are not available. Clinical characteristics may only insufficiently predict the individual course of disease. Experimental Design: Using the EU-RHAB database, we analyzed a cohort of 121 patients with eMRT clinically.

Mar 1, 2023 | resmedjournal.com | Matthias Held |Elena Pfeuffer-Jovic |Heinrike Wilkens |Homburg Saar

The influence of the new pulmonary hypertension (PH) definition on the incidence of chronic thromboembolic PH (CTEPH) is unclear. The incidence of chronic thromboembolic pulmonary disease without PH (CTEPD) is unknown. To determine the frequency of CTEPH and CTEPD using the new mPAP cut-off >20 mmHg for PH in patients who have suffered an incidence of pulmonary embolism (PE) and were recruited into an aftercare program.